Comeback for the camptothecins?
Kirschbaum
Mark
M
Department of Hematology & Hematopoetic Cell Transplantation, City of Hope National Cancer Center, Duarte, CA 91010, USA. mkirschbaum@coh.org
D000328:Adult; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D000077146:Irinotecan; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy*; D012074:Remission Induction; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous; D016896:Treatment Outcome
D000972:Antineoplastic Agents, Phytogenic; D000077146:Irinotecan; D002166:Camptothecin